Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Treasury Shares (2022 - 2025)

Caribou Biosciences (CRBU) has disclosed Treasury Shares for 4 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 67.52% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, up 67.52% year-over-year, with the annual reading at $2.2 million for FY2025, 67.52% up from the prior year.
  • Treasury Shares for Q4 2025 was $2.2 million at Caribou Biosciences, down from $2.2 million in the prior quarter.
  • The five-year high for Treasury Shares was $2.2 million in Q3 2025, with the low at $60000.0 in Q1 2022.
  • Average Treasury Shares over 4 years is $929810.4, with a median of $720158.5 recorded in 2022.
  • The sharpest move saw Treasury Shares tumbled 35.16% in 2023, then soared 673.49% in 2024.
  • Over 4 years, Treasury Shares stood at $256146.0 in 2022, then dropped by 19.83% to $205357.0 in 2023, then surged by 531.74% to $1.3 million in 2024, then skyrocketed by 67.52% to $2.2 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $2.2 million, $2.2 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.